Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

The American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

GOYA, published by the esteemed FUNDACION LAZARO GALDIANO, is a pivotal journal in the field of Visual Arts and Performing Arts. With an ISSN of 0017-2715, this Spanish journal serves as a critical platform for scholars, artists, and practitioners to engage with contemporary issues, trends, and methodologies in the arts. Since its inception, GOYA has strived to illuminate the intersection of artistic expression and cultural discourse, with coverage spanning from 2002 to 2024. The journal proudly holds a Q3 category ranking in the 2023 Scopus assessments for its field, reflecting its respected position among peers, with a notable rank of #377 out of 667. Though it does not follow an Open Access model, GOYA continues to contribute significantly to the academic landscape, enabling a deeper understanding of artistic practices and their societal implications. Researchers and students alike will find the journal an invaluable resource for insights and inspiration within the dynamic realm of the arts.

Diabetes Therapy is a prominent open access journal published by SPRINGER HEIDELBERG, dedicated to advancing our understanding of diabetes management and therapeutic strategies. Since its inception in 2010, the journal has provided a platform for high-quality research, showcasing innovative studies and clinical advances aimed at improving care for individuals with diabetes. With an established impact factor and categorized within the Q2 quartile in both Endocrinology, Diabetes and Metabolism and Internal Medicine in 2023, it ranks among the top journals in its field, reflecting its significant contribution to medical knowledge. Researchers, healthcare professionals, and students benefit from its comprehensive coverage of critical topics, ranging from pharmacological advancements to lifestyle interventions and cutting-edge technologies in diabetes management. With a Scopus rank placing it 35th in Internal Medicine, and 68th in Endocrinology, Diabetes, and Metabolism, Diabetes Therapy is recognized for its robust peer-reviewed content, making it an essential resource for anyone engaged in diabetes research and care.

Oxford Art Journal, published by Oxford University Press, serves as a vital platform for scholarly discourse in the fields of History, Visual Arts, and Performing Arts. With an ISSN of 0142-6540 and an E-ISSN of 1741-7287, this esteemed journal has cultivated a rich academic presence since its inception, reflecting a deep commitment to exploring the intricacies of art history and contemporary visual culture. Holding a Q2 ranking in Visual Arts and Performing Arts and a Q3 ranking in History for the year 2023, the journal features rigorous peer-reviewed articles that push the boundaries of research and offer new insights into artistic practices. Although not offering open access, the journal is widely respected for its contributions to the academic community, making it invaluable for researchers, professionals, and students deeply engaged in art studies. For those seeking a comprehensive understanding of the visual arts landscape, the Oxford Art Journal remains an indispensable resource.

JRSM Cardiovascular Disease is a leading open-access journal published by SAGE Publications Ltd, dedicated to promoting research and knowledge dissemination in the vital field of cardiovascular health. Established in 2012, the journal plays a pivotal role in advancing the understanding of cardiovascular diseases through peer-reviewed articles, clinical studies, and innovative research findings. With a focus on enhancing patient care and public health, it aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. By facilitating open access to its content, JRSM Cardiovascular Disease ensures that significant discoveries and advancements are available to a global audience, thereby contributing to the ongoing dialogue and collaboration within the cardiovascular disease community. This journal not only highlights critical advancements but also fosters an environment for continuous education and improvement in the field.

JACC-Heart Failure is a premier journal in the field of cardiology, published by Elsevier Science Ltd, that has rapidly established itself as a vital resource for researchers and practitioners focused on heart failure and cardiovascular health. With an impressive impact factor and ranking in the Q1 category for Cardiology and Cardiovascular Medicine, this journal is recognized for its high-quality peer-reviewed articles that contribute significantly to advancements in clinical practice and scientific understanding of heart failure. As of 2023, the journal ranks #10 out of 387 in its field, positioning it in the 97th percentile of Scopus rankings, which highlights its influential role in disseminating cutting-edge research. Although the journal does not operate under an open-access model, it maintains a rigorous review process, ensuring the publication of articles that are both innovative and clinically relevant. Targeting an audience of dedicated researchers, healthcare professionals, and students, JACC-Heart Failure serves as an essential platform for exploring the complexities of heart failure treatments, management strategies, and future directions in cardiology.

Umeni-Art is a prominent journal in the field of visual arts and performing arts, published by the Institute of Art History, Academy of Sciences, Czech Republic. With its ISSN 0049-5123 and E-ISSN 1804-6509, the journal has established itself as a critical platform for scholarly discourse and artistic expression since its inception in 2002. Although currently classified in Q4 within the Arts and Humanities category, it aims to elevate the understanding and appreciation of the arts through rigorous research and innovative perspectives. The journal's Scopus ranking places it at Rank #573/667, reflecting its growing contribution to the field and expanding reach within the artistic community. With a focus on fostering collaboration among researchers, practitioners, and students, Umeni-Art seeks to enrich the academic landscape with significant findings and discussions that inspire future research and creative endeavors. While it does not offer open access, the journal remains a valuable resource for those vested in exploring the dynamic interplay between art, culture, and society in the contemporary context.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.